GR
LinkedIn

Goutam Reddy

Founder, CEO

San Francisco Bay Area · 1 connection

Abiogenix

Not on Unlinked · Imported profile. Is this you? Claim it

About

My mission is to improve physical and mental health using connected technologies. I'm currently working on conversational AI to improve personalization in behavior change, starting with our medication adherence technologies. Our smart pill boxes and app ( help people remember to take their medications on time and help people look after their loved ones. We're currently doing a clinical trial with Johns Hopkins, to see if our pillboxes and real-time messaging can induce improved medication adherence for young adults taking anti-rejection medications. I've prototyped some AI-enabled tools to enable AI-therapy ( personal spiritual exploration ( and help voters understand their ballots ( In response to the Covid-19 crisis, I led the development, manufacture, and commercialization of a novel 3d-printed nasopharyngeal swab for covid testing ( When supply-chain from China was shutdown, we manufactured 1.4M swabs in the US and got them out to health systems across the US. Previous health technology experience designing digital surgical tools (Eidosmed), coding data collection and spectral analysis of ECoG motor control experiments (University of Iowa), and advanced sensing/control of prost

Experience

Founder, CEOAbiogenix
Aug 2018
Co-Founder, Director of IOTManifold Basic company page — company details not listed yet
Mar 2017 to Aug 2018
Founder, CEOAbiogenix
Jan 2007 to Jun 2017
Director of Mobile TechnologyHTC Global Services
Sep 2011 to Sep 2012
R&D; EngineeringEidosmed
Jan 2009 to Dec 2009
Senior Developer, Advanced Development GroupChamberlain Group
Jan 2009 to Dec 2009
R&D; EEMolysym
Jan 2003 to Dec 2005

Education

Massachusetts Institute of Technology
Master’s Degree EECS
2002 to 2005
Massachusetts Institute of Technology
BS EECS, Mathematics
1998 to 2002
Northwestern University - The Feinberg School of Medicine
M2
2009 to 2011
Quantic School of Business and Technology
Executive MBA Business
2022 to 2023